Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Temple University 2001
• 

  Duke Appointment History

  • Adjunct Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2013
• Recognition
• 

  Awards & Honors

  • Fellow. American Statistical Association. 2016
• Expertise
• 

  Subject Headings

  • Breast Neoplasms
  • Cohort Studies
  • Colorectal Neoplasms
  • Gastrointestinal Hormones
  • Gastrointestinal Tract
  • Italy
  • Lung Neoplasms
  • Models, Statistical
  • Neoplasm Invasiveness
  • Prognosis
  • Socioeconomic Factors
  • Survival Analysis
  • Thyroid Neoplasms
  • Thyroidectomy
  • Urogenital System
• Research
• 

  Selected Grants

  • Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS awarded by Alliance for Clinical Trials in Oncology Foundation 2016 - 2021
  • Translational Research in Surgical Oncology awarded by National Institutes of Health 2002 - 2021
  • Targeting RNA splicing in race-related aggressive and lethal prostate cancer awarded by Prostate Cancer Foundation 2018 - 2020
  • Helicobacter pylori blood biomarker for gastric cancer risk in East Asia awarded by National Institutes of Health 2017 - 2020
  • Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer awarded by National Institutes of Health 2017 - 2020
  • Personal Service Agreement (PSA) Gu awarded by Institute for Medical Research, Inc. 2018 - 2019
  • IPA - Terry Hyslop awarded by Durham Veterans Affairs Medical Center 2017 - 2019
  • Epigenetic damage in women living in LA food-desert zip codes awarded by City of Hope 2017 - 2019
  • Combined breast MRI/biomarker strategies to identify aggressive biology awarded by City of Hope 2015 - 2019
  • Microscaled Proteogenomics for Cancer Clinical Trials awarded by Baylor College of Medicine 2017 - 2019
  • Innovative Biomarker-Integrated Clinical Trial Design and Analysis awarded by University of North Carolina - Chapel Hill 2015 - 2019
  • IPA - Lin Gu awarded by Durham Veterans Affairs Medical Center 2017 - 2018
  • The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk awarded by National Institutes of Health 2016 - 2018
  • Tension-Stat3-miR-mediated Metastasis awarded by City of Hope 2015 - 2018
  • Breast Cancer Research Foundation awarded by Alliance for Clinical Trials in Oncology Foundation 2015 - 2017
  • National Clinical Trials Network - Network Group Statistics and DMCs awarded by Mayo Clinic 2014 - 2017
  • Tension-Stat3-miR-mediated Metastasis awarded by City of Hope 2015 - 2017
  • Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia awarded by National Institutes of Health 2015 - 2017
  • Small RNA Sequencing and prospective evaluation of HCC risk in HBV patients awarded by Thomas Jefferson University 2014 - 2016
  • Combined breast MRI/biomarker strategies to identify aggressive biology awarded by National Institutes of Health 2015
  • Tension-Stat3-miR-mediated metastasis awarded by University of California - San Francisco 2015
  • Structural Models of Breast Cancer Outcomes Disparities awarded by Susan G Komen for the Cure 2014 - 2015
  • Therapy-relevant stratification of breast cancer patients: Integrating pathology and biomarkers analysis awarded by Thomas Jefferson University 2014 - 2015
  • Occult tumor burden as a marker stratifying therapy to eliminate racial disparities in colon cancer awarded by Thomas Jefferson University 2014
  • Tumor MicroRNA Signatures as Prognostic Biomarkers of Colorectal Cancer awarded by Thomas Jefferson University 2014
  • Therapeutic vaccine bridging the gap in racial disparities in colorectal cancer awarded by Thomas Jefferson University 2014
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Snook, AE, Baybutt, TR, Xiang, B, Abraham, TS, Flickinger, JC, Hyslop, T, Zhan, T, Kraft, WK, Sato, T, and Waldman, SA. "Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients." Journal for Immunotherapy of Cancer 7, no. 1 (April 23, 2019): 104-null.  Full Text
    • Lane, WO, Thomas, SM, Blitzblau, RC, Plichta, JK, Rosenberger, LH, Fayanju, OM, Hyslop, T, Hwang, ES, and Greenup, RA. "Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis." Annals of Surgery 269, no. 3 (March 2019): 537-544.  Full Text
    • Tran, TH, Utama, FE, Sato, T, Peck, AR, Langenheim, JF, Udhane, SS, Sun, Y, Liu, C, Girondo, MA, Kovatich, AJ, Hooke, JA, Shriver, CD, Hu, H, Palazzo, JP, Bibbo, M, Auer, PW, Flister, MJ, Hyslop, T, Mitchell, EP, Chervoneva, I, and Rui, H. "Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 24, no. 24 (December 2018): 6355-6366.  Full Text
    • Tanioka, M, Fan, C, Parker, JS, Hoadley, KA, Hu, Z, Li, Y, Hyslop, TM, Pitcher, BN, Soloway, MG, Spears, PA, Henry, LN, Tolaney, S, Dang, CT, Krop, IE, Harris, LN, Berry, DA, Mardis, ER, Winer, EP, Hudis, CA, Carey, LA, and Perou, CM. "Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 24, no. 21 (November 2018): 5292-5304.  Full Text
    • Fayanju, OM, Ren, Y, Thomas, SM, Greenup, RA, Plichta, JK, Rosenberger, LH, Tamirisa, N, Force, J, Boughey, JC, Hyslop, T, and Hwang, ES. "The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)." Annals of Surgery 268, no. 4 (October 2018): 591-601.  Full Text
    • Force, J, Howie, LJ, Abbott, SE, Bentley, R, Marcom, PK, Kimmick, G, Westbrook, K, Sammons, SL, Parks, M, Topping, DL, Emerson, R, Broadwater, G, Hyslop, T, Blackwell, KL, and Nair, SK. "Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype." Clinical Breast Cancer 18, no. 5 (October 2018): 410-417.  Full Text
    • Park, TS, Thomas, SM, Rosenberger, LH, Fayanju, OM, Plichta, JK, Blitzblau, RC, Ong, CT, Hyslop, T, Hwang, ES, and Greenup, RA. "The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer." Annals of Surgical Oncology 25, no. 10 (October 2018): 3019-3029.  Full Text
    • Tamirisa, N, Thomas, SM, Fayanju, OM, Greenup, RA, Rosenberger, LH, Hyslop, T, Hwang, ES, and Plichta, JK. "Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival." Annals of Surgical Oncology 25, no. 10 (October 1, 2018): 2890-2898.  Full Text
    • Chervoneva, I, Freydin, B, Hyslop, T, and Waldman, SA. "Modeling qRT-PCR dynamics with application to cancer biomarker quantification." Statistical Methods in Medical Research 27, no. 9 (September 2018): 2581-2595.  Full Text
    • Ong, CT, Campbell, BM, Thomas, SM, Greenup, RA, Plichta, JK, Rosenberger, LH, Force, J, Hall, A, Hyslop, T, Hwang, ES, and Fayanju, OM. "Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database." Annals of Surgical Oncology 25, no. 8 (August 2018): 2249-2260.  Full Text
    • Freedman, JA, Wang, Y, Li, X, Liu, H, Moorman, PG, George, DJ, Lee, NH, Hyslop, T, Wei, Q, and Patierno, SR. "Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival." Carcinogenesis 39, no. 7 (July 2018): 879-888.  Full Text  Open Access Copy
    • Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Reply to: "Surgeon Volume Threshold for Total Thyroidectomy"." Annals of Surgery 267, no. 4 (April 2018): e78-e79. (Letter)  Full Text
    • Grimm, Lars J., Marc D. Ryser, and Terry Hyslop. “Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ..” Jama Surgery 153, no. 3 (March 2018): 290–91. https://doi.org/10.1001/jamasurg.2017.5566.
       Full Text
    • Magbanua, MJM, Rugo, HS, Wolf, DM, Hauranieh, L, Roy, R, Pendyala, P, Sosa, EV, Scott, JH, Lee, JS, Pitcher, B, Hyslop, T, Barry, WT, Isakoff, SJ, Dickler, M, Van't Veer, L, and Park, JW. "Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 24, no. 6 (March 2018): 1486-1499.  Full Text
    • Greenup, RA, Obeng-Gyasi, S, Thomas, S, Houck, K, Lane, WO, Blitzblau, RC, Hyslop, T, and Hwang, ES. "The Effect of Hospital Volume on Breast Cancer Mortality." Annals of Surgery 267, no. 2 (February 2018): 375-381.  Full Text
    • Xu, Y, Wang, Y, Liu, H, Shi, Q, Zhu, D, Amos, CI, Fang, S, Lee, JE, Hyslop, T, Li, X, Han, J, and Wei, Q. "Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival." Molecular Carcinogenesis 57, no. 1 (January 2018): 22-31.  Full Text  Open Access Copy
    • Ong, CT, Thomas, SM, Blitzblau, RC, Fayanju, OM, Park, TS, Plichta, JK, Rosenberger, LH, Hyslop, T, Shelley Hwang, E, and Greenup, RA. "Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011." Annals of Surgical Oncology 24, no. 12 (November 2017): 3559-3566.  Full Text
    • Adam, MA, Thomas, S, Roman, SA, Hyslop, T, and Sosa, JA. "Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer." Jama Surgery 152, no. 9 (September 2017): 869-876.  Full Text
    • Li, P, Wuthrick, E, Rappaport, JA, Kraft, C, Lin, JE, Marszalowicz, G, Snook, AE, Zhan, T, Hyslop, TM, and Waldman, SA. "GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome." Cancer Research 77, no. 18 (September 2017): 5095-5106.  Full Text
    • Liu, S, Wang, Y, Xue, W, Liu, H, Xu, Y, Shi, Q, Wu, W, Zhu, D, Amos, CI, Fang, S, Lee, JE, Hyslop, T, Li, Y, Han, J, and Wei, Q. "Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival." International Journal of Cancer 141, no. 4 (August 2017): 721-730.  Full Text
    • Wang, Y, Freedman, JA, Liu, H, Moorman, PG, Hyslop, T, George, DJ, Lee, NH, Patierno, SR, and Wei, Q. "Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer." International Journal of Cancer 141, no. 4 (August 2017): 731-743.  Full Text
    • Anand, S, Thomas, S, Hyslop, T, Adcock, J, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 7 (July 2017): 1151-1157.  Full Text
    • Cheng, Q, Li, X, Acharya, CR, Hyslop, T, and Sosa, JA. "A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors." Oncotarget 8, no. 10 (March 2017): 16690-16703.  Full Text
    • Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?." Annals of Surgery 265, no. 2 (February 2017): 402-407.  Full Text
    • Hwang, E Shelley, and Terry Hyslop. “Reply to J. Heil et al..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 34 (December 2016). https://doi.org/10.1200/jco.2016.69.1121.
       Full Text
    • Snook, Adam E., Trevor R. Baybutt, Terry Hyslop, and Scott A. Waldman. “Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope..” Human Gene Therapy Methods 27, no. 6 (December 2016): 238–50. https://doi.org/10.1089/hgtb.2016.114.
       Full Text
    • Adam, MA, Thomas, S, Hyslop, T, Scheri, RP, Roman, SA, and Sosa, JA. "Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 36 (December 2016): 4415-4420.  Full Text
    • Kim, Edward, Michaela Dinan, Km Monirul Islam, Ancilla Fernandes, Lee Schwartzberg, Elisabeth Croft, Julie Brahmer, et al. “PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology..” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 11, no. 11S (November 2016): S308–9. https://doi.org/10.1016/j.jtho.2016.09.096.
       Full Text
    • Peck, AR, Girondo, MA, Liu, C, Kovatich, AJ, Hooke, JA, Shriver, CD, Hu, H, Mitchell, EP, Freydin, B, Hyslop, T, Chervoneva, I, and Rui, H. "Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms." Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc 29, no. 10 (October 2016): 1143-1154.  Full Text
    • Robinson, TJ, Thomas, S, Dinan, MA, Roman, S, Sosa, JA, and Hyslop, T. "How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 28 (October 2016): 3434-3439.  Full Text
    • Sung, AD, Sung, JAM, Thomas, S, Hyslop, T, Gasparetto, C, Long, G, Rizzieri, D, Sullivan, KM, Corbet, K, Broadwater, G, Chao, NJ, and Horwitz, ME. "Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 63, no. 8 (October 2016): 999-1006.  Full Text
    • Hwang, E Shelley, Tracie D. Locklear, Christel N. Rushing, Greg Samsa, Amy P. Abernethy, Terry Hyslop, and Dunya M. Atisha. “Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy.” Journal of Clinical Oncology 34, no. 13 (May 1, 2016): 1518-+. https://doi.org/10.1200/JCO.2015.61.5427.
       Full Text  Link to Item
    • Lai, Y, Wang, C, Civan, JM, Palazzo, JP, Ye, Z, Hyslop, T, Lin, J, Myers, RE, Li, B, Jiang, B, Sama, A, Xing, J, and Yang, H. "Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study." Gastroenterology 150, no. 5 (May 2016): 1135-1146.  Full Text
    • Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?." Annals of Surgery (March 8, 2016).
    • Goodman, C. R., T. Sato, A. R. Peck, M. A. Girondo, N. Yang, C. Liu, A. F. Yanac, et al. “Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism..” Oncogene 35, no. 11 (March 2016): 1373–85. https://doi.org/10.1038/onc.2015.193.
       Full Text
    • Palumbo, A, Michael, Y, and Hyslop, T. "Latent class model characterization of neighborhood socioeconomic status." Cancer Causes & Control : Ccc 27, no. 3 (March 2016): 445-452.  Full Text
    • He, K, Li, Y, Zhu, J, Liu, H, Lee, JE, Amos, CI, Hyslop, T, Jin, J, Lin, H, Wei, Q, and Li, Y. "Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates." Bioinformatics (Oxford, England) 32, no. 1 (January 2016): 50-57.  Full Text  Open Access Copy
    • Lin, JE, Colon-Gonzalez, F, Blomain, E, Kim, GW, Aing, A, Stoecker, B, Rock, J, Snook, AE, Zhan, T, Hyslop, TM, Tomczak, M, Blumberg, RS, and Waldman, SA. "Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis." Cancer Research 76, no. 2 (January 2016): 339-346.  Full Text
    • Mu, Z, Wang, C, Ye, Z, Austin, L, Civan, J, Hyslop, T, Palazzo, JP, Jaslow, R, Li, B, Myers, RE, Jiang, J, Xing, J, Yang, H, and Cristofanilli, M. "Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer." Breast Cancer Research and Treatment 154, no. 3 (December 2015): 563-571.  Full Text
    • Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Reed, SD, Scheri, RP, Hyslop, T, Roman, SA, and Sosa, JA. "Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33, no. 21 (July 2015): 2370-2375.  Full Text
    • Showalter, Timothy N., Sarah E. Hegarty, Carol Rabinowitz, Vittorio Maio, Terry Hyslop, Adam P. Dicker, and Daniel Z. Louis. “Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy..” International Journal of Radiation Oncology, Biology, Physics 91, no. 4 (March 2015): 752–59. https://doi.org/10.1016/j.ijrobp.2014.11.038.
       Full Text
    • Adam, M. A., J. Pura, P. Goffredo, M. A. Dinan, T. Hyslop, S. D. Reed, R. P. Scheri, S. A. Roman, and J. A. Sosa. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.” Journal of Clinical Endocrinology and Metabolism 100, no. 1 (2015): 115–21. https://doi.org/10.1210/jc.20143039.
       Full Text
    • Wang, Chun, Jesse Civan, Yinzhi Lai, Massimo Cristofanilli, Terry Hyslop, Juan P. Palazzo, Ronald E. Myers, et al. “Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables..” Cancer Causes & Control : Ccc 26, no. 1 (January 2015): 45–56. https://doi.org/10.1007/s10552-014-0481-4.
       Full Text
    • Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years." The Journal of Clinical Endocrinology and Metabolism 100, no. 1 (January 2015): 115-121.  Full Text
    • Hegarty, SE, Hyslop, T, Dicker, AP, and Showalter, TN. "Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort." Plos One 10, no. 2 (January 2015): e0118430-null.  Full Text
    • Lin, J, Deng, A, Hoffman-Censits, J, Gibney, G, Hyslop, T, Miller, B, Kilpatrick, D, Jabbour, S, and Kevin Kelly, W. "An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients." Cancer Treatment Communications 4 (January 1, 2015): 192-195.  Full Text
    • Zhang, K, Lai, Y, Axelrod, R, Campling, B, Hyslop, T, Civan, J, Solomides, C, Myers, RE, Lu, B, Bar Ad, V, Li, B, Ye, Z, and Yang, H. "Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests." International Journal of Cancer 136, no. 2 (January 1, 2015): 382-391.  Full Text
    • Wilson, C, Lin, JE, Li, P, Snook, AE, Gong, J, Sato, T, Liu, C, Girondo, MA, Rui, H, Hyslop, T, and Waldman, SA. "The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 23, no. 11 (November 2014): 2328-2337.  Full Text
    • Chen, Y, Kovatich, AJ, Fantacone-Campbell, JL, Hooke, JA, Kvecher, L, Kovatich, AW, Gallagher, CM, Hueman, MT, Hyslop, T, Mural, RJ, Shriver, CD, Rui, H, and Hu, H. "Abstract P4-06-09: HER2+ and HER2- luminal B subtypes have similar overall survival and histologic grade distributions." Cancer Research 73, no. 24 Supplement (December 15, 2013).  Full Text
    • Girondo, MA, Peck, AR, Freydin, B, Chervoneva, I, Hyslop, T, Kovatich, AJ, Hooke, JA, Shriver, CD, Mitchell, EP, and Rui, H. "Abstract P1-08-20: Increased risk of hormone therapy failure in breast cancers expressing low phospho-Stat5: Validation of quantitative immunofluorescence assay parameters." Cancer Research 73, no. 24 Supplement (December 15, 2013).  Full Text
    • Kovatich, AJ, Chen, Y, Fantacone-Campbell, JL, Wareham, JA, Tafra, L, Kvecher, L, Hyslop, T, Hooke, JA, Rui, H, Shriver, CD, Mural, RJ, and Hu, H. "Abstract P4-06-03: Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient." Cancer Research 73, no. 24 Supplement (December 15, 2013).  Full Text
    • Hyslop, T, Michael, Y, Avery, T, and Rui, H. "Population and target considerations for triple-negative breast cancer clinical trials." Biomarkers in Medicine 7, no. 1 (February 2013): 11-21. (Review)  Full Text
    • Lin, JE, Snook, AE, Li, P, Stoecker, BA, Kim, GW, Magee, MS, Garcia, AVM, Valentino, MA, Hyslop, T, Schulz, S, and Waldman, SA. "GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity." Plos One 7, no. 2 (January 2012): e31686-null.  Full Text
    • Peck, A. R., A. K. Witkiewicz, C. Liu, A. C. Klimowicz, G. A. Stringer, E. Pequignot, B. Freydin, et al. “P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome..” Cancer Research 71, no. 24 Supplement (December 15, 2011). https://doi.org/10.1158/0008-5472.sabcs11-p1-06-24.
       Full Text
    • Peck, Amy R., Agnieszka K. Witkiewicz, Chengbao Liu, Ginger A. Stringer, Alexander C. Klimowicz, Edward Pequignot, Boris Freydin, et al. “Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29, no. 18 (June 2011): 2448–58. https://doi.org/10.1200/JCO.2010.30.3552.
       Full Text
    • Peck, Amy R., Agnieszka K. Witkiewicz, Chengbao Liu, Ginger A. Stringer, Alexander C. Klimowicz, Edward Pequignot, Boris Freydin, et al. “Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer.” Cancer Research 71, no. 8 Supplement (April 15, 2011): 2277–2277. https://doi.org/10.1158/1538-7445.am2011-2277.
       Full Text
    • Chervoneva, Inna, Yanyan Li, Stephanie Schulz, Sean Croker, Chantell Wilson, Scott A. Waldman, and Terry Hyslop. “Selection of optimal reference genes for normalization in quantitative RT-PCR..” Bmc Bioinformatics 11 (May 14, 2010). https://doi.org/10.1186/1471-2105-11-253.
       Full Text
    • Waldron, Todd J., Angele R. Soliera, Ying Zhang, Robert Martinez, Terry Hyslop, Timothy Bender, and Bruno Calabretta. “Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1.” Cancer Research 70, no. 8 Supplement (April 15, 2010): 5061–5061. https://doi.org/10.1158/1538-7445.am10-5061.
       Full Text
    • Lin, JE, Li, P, Snook, AE, Schulz, S, Dasgupta, A, Hyslop, TM, Gibbons, AV, Marszlowicz, G, Pitari, GM, and Waldman, SA. "The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling." Gastroenterology 138, no. 1 (January 2010): 241-254.  Full Text
    • Waldman, Scott A., Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, and David S. Weinberg. “Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer..” Jama 301, no. 7 (February 2009): 745–52. https://doi.org/10.1001/jama.2009.141.
       Full Text
    • Yu, Z, Wang, C, Wang, M, Li, Z, Casimiro, MC, Liu, M, Wu, K, Whittle, J, Ju, X, Hyslop, T, McCue, P, and Pestell, RG. "A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation." The Journal of Cell Biology 182, no. 3 (August 2008): 509-517.  Full Text
    • Waldman, S. A., T. Hyslop, S. Schulz, K. Nielsen, J. Haaf, C. Bonaccorso, Y. Li, A. Barkun, and D. Weinberg. “A prospective multicenter study of guanylyl cyclase C (GCC), quantified by the reverse transcriptase-polymerase chain reaction (qRT-PCR), as a prognostic marker of occult metastases in lymph nodes of pN0 colorectal cancer patients..” J Clin Oncol 26, no. 15_suppl (May 20, 2008).
       Link to Item
    • Witkiewicz, A., A. Ryder, L. M. Neilson, F. E. Utama, T. H. Tran, T. Hyslop, and H. Rui. “Transcription factors Stat5a and Stat5b: Favorable prognostic markers in breast cancer..” J Clin Oncol 26, no. 15_suppl (May 20, 2008).
       Link to Item
    • Chervoneva, I, Li, Y, Iglewicz, B, Waldman, S, and Hyslop, T. "Relative quantification based on logistic models for individual polymerase chain reactions." Statistics in Medicine 26, no. 30 (December 2007): 5596-5611.  Full Text
    • Calin, GA, Liu, C-G, Ferracin, M, Hyslop, T, Spizzo, R, Sevignani, C, Fabbri, M, Cimmino, A, Lee, EJ, Wojcik, SE, Shimizu, M, Tili, E, Rossi, S, Taccioli, C, Pichiorri, F, Liu, X, Zupo, S, Herlea, V, Gramantieri, L, Lanza, G, Alder, H, Rassenti, L, Volinia, S, Schmittgen, TD, Kipps, TJ, Negrini, M, and Croce, CM. "Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas." Cancer Cell 12, no. 3 (September 2007): 215-229.  Full Text
    • Chervoneva, Inna, Boris Iglewicz, and Terry Hyslop. “A general approach for two-stage analysis of multilevel clustered non-Gaussian data..” Biometrics 62, no. 3 (September 2006): 752–59. https://doi.org/10.1111/j.1541-0420.2005.00512.x.
       Full Text
    • Calin, GA, Sevignani, C, Dumitru, CD, Hyslop, T, Noch, E, Yendamuri, S, Shimizu, M, Rattan, S, Bullrich, F, Negrini, M, and Croce, CM. "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers." Proceedings of the National Academy of Sciences of the United States of America 101, no. 9 (March 2004): 2999-3004.  Full Text
    • Ober, C, Hyslop, T, Elias, S, Weitkamp, LR, and Hauck, WW. "Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study." Human Reproduction (Oxford, England) 13, no. 1 (January 1998): 33-38.  Full Text

  • Conference Papers

    • Turner, MC, Keenan, JE, Rushing, CN, Gulack, BC, Nussbaum, DP, Benrashid, E, Hyslop, T, Strickler, JH, Mantyh, CR, and Migaly, J. "Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response." January 11, 2019.  Full Text
    • Butt, J, Varga, MG, Blot, WJ, Teras, L, Visvanathan, K, Le Marchand, L, Haiman, C, Chen, Y, Bao, Y, Sesso, HD, Wassertheil-Smoller, S, Ho, GYF, Tinker, LE, Peek, RM, Potter, JD, Cover, TL, Hendrix, LH, Huang, L-C, Hyslop, T, Um, C, Grodstein, F, Song, M, Zeleniuch-Jacquotte, A, Berndt, S, Hildesheim, A, Waterboer, T, Pawlita, M, and Epplein, M. "Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States." January 2019.  Full Text
    • Greenup, Rachel Adams, Laura Fish, Christel Rushing, Jeffrey Peppercorn, Terry Hyslop, Yousuf Zafar, and E Shelley Hwang. “The Financial Burden of Breast Cancer Treatment.” In Journal of Womens Health, 26:1022–1022. MARY ANN LIEBERT, INC, 2017.
       Link to Item
    • Campbell, Brittany Morgan, Samantha Marie Thomas, Cecilia Tuongquang Ong, Rachel Adams Greenup, Jennifer Kay Plichta, Laura Horst Rosenberger, Jeremy Meyer Force, Terry Hyslop, Eun-Sil Shelley Hwang, and Oluwadamilola Motunrayo Fayanju. “The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database..” In Journal of Clinical Oncology, 35:1570–1570. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.1570.
       Full Text
    • Greenup, Rachel Adams, Samantha Marie Thomas, Oluwadamilola Motunrayo Fayanju, Terry Hyslop, and Eun-Sil Shelley Hwang. “Impact of insurance status on treatment for stage 0-IV breast cancer..” In Journal of Clinical Oncology, 35:6532–6532. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.6532.
       Full Text
    • Musselwhite, Laura W., Thomas S. Redding, Kellie J. Sims, Meghan O’Leary, Elizabeth R. Hauser, Terry Hyslop, David A. Lieberman, and Dawn T. Provenzale. “Validation of the NCI colorectal cancer risk assessment tool in the CSP 380 veterans cohort..” In Journal of Clinical Oncology, 35:e15135–e15135. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.e15135.
       Full Text
    • Martin, M, Loibl, S, Hyslop, T, de la Haba-Rodriguez, J, Aktas, B, Cirrincione, C, Carrasco, EM, Mehta, K, Barry, WT, Morales, S, Carey, LA, Garcia Saenz, JA, Partridge, A, Martinez, N, Hahn, OM, Winer, EP, Guerrero, A, Hudis, C, Casas, M, and Dickler, MN. "Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials." : American Society of Clinical Oncology (ASCO), May 20, 2017.  Full Text
    • Narloch, J, Luedke, C, Broadwater, G, Priedigkeit, N, Hall, A, Hyslop, T, Sammons, SL, Huggins-Puhalla, SL, Leone, JP, Ramirez, J, Kirkpatrick, JP, Ewend, MG, Fecci, PE, Brufsky, A, Lee, AV, Anders, CK, and Blackwell, KL. "Number of tumor-infiltrating lymphocytes in breast cancer brain metastases compared to matched breast primaries." : American Society of Clinical Oncology (ASCO), May 20, 2017.  Full Text
    • Ong, CT, Thomas, SM, Campbell, BM, Greenup, RA, Plichta, JK, Rosenberger, LH, Force, JM, Hyslop, T, Hwang, E-SS, and Fayanju, OM. "A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients." : American Society of Clinical Oncology (ASCO), May 20, 2017.  Full Text
    • Plichta, JK, Thomas, SM, Fayanju, OM, Rosenberger, LH, Park, TS, Hyslop, T, Greenup, RA, and Hwang, E-SS. "Temporal associations between prognostic indicators and overall survival after breast cancer." : American Society of Clinical Oncology (ASCO), May 20, 2017.  Full Text
    • Hoadley, K. A., T. Hyslop, C. Fan, D. A. Berry, O. Hahn, S. M. Tolaney, W. M. Sikov, C. M. Perou, and L. A. Carey. “Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).” In Cancer Research, Vol. 77. American Association for Cancer Research (AACR), 2017. https://doi.org/10.1158/1538-7445.sabcs16-pd1-03.
       Full Text
    • Tanioka, M., C. Fan, L. A. Carey, T. Hyslop, B. N. Pitcher, J. A. Parker, K. A. Hoadley, et al. “Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer.” In Cancer Research, Vol. 77. American Association for Cancer Research (AACR), 2017. https://doi.org/10.1158/1538-7445.sabcs16-s3-05.
       Full Text
    • Force, J, Abbott, S, Broadwater, G, Kimmick, G, Westbrook, K, Hwang, S, Kauff, N, Stashko, I, Weinhold, K, Nair, S, Hyslop, T, Blackwell, K, Castellar, E, and Marcom, PK. "Abstract P2-04-19: Elucidating the tumor immune microenvironment phenotype in early stage untreated BRCA mutated breast cancer patients." : American Association for Cancer Research (AACR), February 15, 2017.  Full Text
    • Narloch, JL, Harnden, K, Broadwater, G, Peterson, B, Hyslop, T, Kirkpatrick, J, Fecci, P, Kim, G, and Blackwell, KL. "Abstract P5-08-12: HER2 status remains the primary predictor of improved survival in patients with BCBM over the past 2 decades (1996-2015)." : American Association for Cancer Research (AACR), February 15, 2017.  Full Text
    • Hwang, E Shelley, Tracie D. Locklear, Christel N. Rushing, Greg Samsa, Amy P. Abernethy, Terry Hyslop, and Dunya M. Atisha. “Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy..” In Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 34:1518–27, 2016. https://doi.org/10.1200/jco.2015.61.5427.
       Full Text
    • Hyslop, T., M. Alvarado, A. Forero, M. Golshan, T. Hieken, J. Horton, C. Hudis, et al. “Abstract S3-06: Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis of TBCRC 017.” In Cancer Research, Vol. 76. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7445.sabcs15-s3-06.
       Full Text
    • Palumbo, A, Michael, Y, and Hyslop, T. "Abstract 4137: Latent class model characterization of neighborhood SES." : American Association for Cancer Research (AACR), October 1, 2014.  Full Text
    • Eberhardt, J. S., T. Hyslop, E. Mitchell, H. Hu, and H. Rui. “Bayesian Belief Network Mortality Analysis of a Breast Cancer Registry Data Set..” In Cancer Research, Vol. 71. AMER ASSOC CANCER RESEARCH, 2011. https://doi.org/10.1158/0008-5472.5ABCS11-P5-14-12.
       Full Text  Link to Item
    • Witkiewicz, Agnieszka, Tran Thai, Ozlem Er, Terry Hyslop, and Hallgeir Rui. “Nuclear expression of transcription factors Stat5a and Stat5b confers favorable prognosis in breast cancer.” In Cancer Research, Vol. 69. AMER ASSOC CANCER RESEARCH, 2009.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.